Y0000370

システム適合性用リスペリドン

European Pharmacopoeia (EP) Reference Standard

• 別名: リスペリドン, R 64,766
• 実験式（ヒル表記法）: C₂₃H₂₇FN₄O₂
• CAS番号: 106266-06-2
• 分子量: 410.48
• MDL番号: MFCD00274576
• UNSPSCコード: 41116107
• PubChem Substance ID: 329830925
• NACRES: NA.24

特性

• グレード: pharmaceutical primary standard
• APIファミリー: risperidone
• メーカー／製品名: EDQM
• アプリケーション: pharmaceutical (small molecule)
• フォーマット: neat
• SMILES記法: CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1
• InChI: 1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3
• InChI Key: RAPZEAPATHNIPO-UHFFFAOYSA-N
• 遺伝子情報: human ... DRD2(1813) , HTR2A(3356) , HTR2C(3358)

詳細

詳細

Risperidone is a new central 5-hydroxytryptamine2 and dopamine D2 antagonist. It is used to treat agitation, aggression,and psychosis caused during demnetia. It is a neuroleptic drug. It is also an atypical antipsychotic drug which is used for treating schizophrenia.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

アプリケーション

Risperidone for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

包装

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS06
• シグナルワード: Danger
• 危険有害性情報: H301
• 注意書き: P301 + P330 + P331 + P310
• 危険有害性の分類: Acute Tox. 3 Oral
• 保管分類コード: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable